Medtech Talk

Lisa Wipperman Heine, COO of Mitralign, says the FDA is making quicker work of review times. But the same might not be said for other countries where Medtechs once had a faster time to market. In this interview at the offices of Fox Rothschild in Minneapolis, the Medtech veteran lays out Mitralign’s success with the agency’s Early Feasibility program.

Steve Clark, senior vice president at Optum Life Sciences, says healthcare rests in the “nascent” stages of questioning effectiveness of medical tech. Successful start-ups will find the right answers to those questions.

Jerry Harrison, rock star turned investor, joined with former Wall Streeter Brian A. Smith to create Red Crow to build a platform for healthcare start-ups to tap the “crowd” as a new source of capital.

Medtech Conference co-chair Stacy Enxing Seng, after succeeding at both start-ups and corporates, shares her enthusiasm for her new role as venture partner at Lightstone Ventures.

Medtech Conference co-chair Kevin Hykes revisits his days at Visiogen and Cameron Health, explaining how those successful outcomes help guide his hand on Metavention’s tiller.

Last month, a surgeon performed ophthalmology’s first robot-assisted surgery – a membrane peel. Marc de Smet, chief medical officer of Preceyes, a Dutch start-up, shares the company’s history and plans for the future.

Backed by nearly $30 million from the Department of Defense, BrainScope created a device to make concussion diagnosis more certain. Hear what’s next for the Medtech start-up.

Ashley McEvoy, Company Group Chairman, Johnson & Johnson Vision Care and Johnson & Johnson Diabetes Care Companies, says the new force could pursue M&A in future expansion. Hear the details of the deal.

Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed is done, and Rox is ready to move forward into the promising hypertension area.